This is an aggregated industry headline. Read the full story at STAT News →
STAT+: Supreme Court to hear case about ‘skinny labeling’ and generic access
The Supreme Court Wednesday will hear oral arguments about a simmering controversy over so-called skinny labels, with implications for the availability of generics.
By STAT News
· Apr 28, 2026
· via STAT News
Tags
policyformat:headlineheadlineSTAT News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Policy
All Policy →
PolicyFierceBiotech ↗
The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in …
PolicyFiercePharma ↗
Eleventh-hour settlements with two of the three generic drugmakers involved could bode well for both Pfizer an…